$ICCM News

IceCure Medical Announces 1-For-30 Reverse Share Split, Effective June 4, 2026

Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ...

IceCure's ProSense® Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked

IceCure Medical Features Cryoablation And ProSense At Annual ECIO 2026

Maxim Group Maintains Buy on Icecure Medical, Lowers Price Target to $1

IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

IceCure (ICCM) Q1 2026 Earnings Transcript

IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue Estimates

IceCure Medical (NASDAQ:ICCM) Shares Slide Over 7% Premarket After Q1 Revenue Miss

IceCure Medical Ltd (ICCM) Q1 2026 Earnings Call Transcript

IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America

Icecure Medical Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $911.000K Miss $1.344M Estimate

IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026

IceCure Showcases ProSense® Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market

IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025

IceCure Medical Reports Preliminary Q1 ProSense U.S. Sales Up 30% YoY

IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement

IceCure Medical shares are trading lower after the company priced a $4 million registered offering.

IceCure Medical shares are trading lower after the company priced a $4 million registered offering.

IceCure Medical Announces Concurrent Private Placement To Isue And Sell Unregistered Series B Warrants To Purchase 8M Shares And Series C Warrants To Purchase 8M Ordinary Shares At Exercise Price Of $0.55/Share